This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ren, M. Articles by Sacchi, N. Search for Related Content PubMed PubMed Citation Articles by Ren, M. Articles by Sacchi, N.

Impaired Retinoic Acid (RA) Signal Leads to RARß2 Epigenetic Silencing and RA Resistance

Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York 14263

Received 25 May 2005/ Returned for modification 13 July 2005/ Accepted 16 September 2005

Resistance to the growth-inhibitory action of retinoic acid (RA), the bioactive derivative of vitamin A, is common in human tumors. One form of RA resistance has been associated with silencing and hypermethylation of the retinoic acid receptor ß2 gene (RARß2), an RA-regulated tumor suppressor gene. The presence of an epigenetically silent RARß2 correlates with lack of the RA receptor (RAR). Normally, RAR regulates RARß2 transcription by mediating dynamic changes of RARß2 chromatin in the presence and absence of RA. Here we show that interfering with RA signal through RAR (which was achieved by use of a dominant-negative RAR, by downregulation of RAR by RNA interference, and by use of RAR antagonists) induces an exacerbation of the repressed chromatin status of RARß2 and leads to RARß2 transcriptional silencing. Further, we demonstrate that RARß2 silencing causes resistance to the growth-inhibitory effect of RA. Apparently, RARß2 silencing can also occur in the absence of DNA methylation. Conversely, we demonstrate that restoration of RA signal at a silent RARß2 through RAR leads to RARß2 reactivation. This report provides proof of principle that RARß2 silencing and RA resistance are consequent to an impaired integration of RA signal at RARß2 chromatin.

This article has been cited by other articles:

• Chakravarti, N., Lotan, R., Diwan, A. H., Warneke, C. L., Johnson, M. M., Prieto, V. G. (2007). Decreased Expression of Retinoid Receptors in Melanoma: Entailment in Tumorigenesis and Prognosis. Clin. Cancer Res. 13: 4817-4824 [Abstract] [Full Text]  
• Trasino, S. E., Harrison, E. H., Wang, T. T. Y. (2007). Androgen Regulation of Aldehyde Dehydrogenase 1A3 (ALDH1A3) in the Androgen-Responsive Human Prostate Cancer Cell Line LNCaP. Exp. Biol. Med. 232: 762-771 [Abstract] [Full Text]  
• Fazi, F., Zardo, G., Gelmetti, V., Travaglini, L., Ciolfi, A., Di Croce, L., Rosa, A., Bozzoni, I., Grignani, F., Lo-Coco, F., Pelicci, P. G., Nervi, C. (2007). Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia. Blood 109: 4432-4440 [Abstract] [Full Text]  
• Bistulfi, G., Pozzi, S., Ren, M., Rossetti, S., Sacchi, N. (2006). A Repressive Epigenetic Domino Effect Confers Susceptibility to Breast Epithelial Cell Transformation: Implications for Predicting Breast Cancer Risk. Cancer Res. 66: 10308-10314 [Abstract] [Full Text]  
• Shelton, D. N., Sandoval, I. T., Eisinger, A., Chidester, S., Ratnayake, A., Ireland, C. M., Jones, D. A. (2006). Up-regulation of CYP26A1 in Adenomatous Polyposis Coli-Deficient Vertebrates via a WNT-Dependent Mechanism: Implications for Intestinal Cell Differentiation and Colon Tumor Development.. Cancer Res. 66: 7571-7577 [Abstract] [Full Text]